Evidence map›Paper›PMID 35163822›Full record

ArticleInternational journal of molecular sciences2022

Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.

Fabienne Hamester, Christine Stürken, Ceren Saygi, Minyue Qi, Karen Legler, Christian Gorzelanny, José R Robador, Barbara Schmalfeldt, Elena Laakmann, Volkmar Müller and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Fabienne HamesterDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Christine StürkenMSH Medical School Hamburg, Faculty of Medicine, Medical University, 20251 Hamburg, Germany.ORCID 0000-0003-3997-3304
Ceren SaygiBioinformatics Core, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Minyue QiBioinformatics Core, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Karen LeglerDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Christian GorzelannyDepartment of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.ORCID 0000-0002-3788-6429
José R RobadorDepartment of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.ORCID 0000-0003-1304-008X
Barbara SchmalfeldtDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Elena LaakmannDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Volkmar MüllerDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.ORCID 0000-0003-4231-7906
Isabell WitzelDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.ORCID 0000-0002-8734-4521
Leticia Oliveira-FerrerDepartment of Gynecology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Universität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain metastases (BM) represent a growing problem for breast cancer (BC) patients. Recent studies have demonstrated a strong impact of the BC molecular subtype on the incidence of BM development. This study explores the interaction between BC cells of different molecular subtypes and the blood-brain barrier (BBB). We compared the ability of BC cells of different molecular subtypes to overcome several steps (adhesion to the brain endothelium, disruption of the BBB, and invasion through the endothelial layer) during cerebral metastases formation, in vitro as well as in vivo. Further, the impact of these cells on the BBB was deciphered at the molecular level by transcriptome analysis of the triple-negative (TNBC) cells themselves as well as of hBMECs after cocultivation with BC cell secretomes. Compared to luminal BC cells, TNBC cells have a greater ability to influence the BBB in vitro and consequently develop BM in vivo. The brain-seeking subline and parental TNBC cells behaved similarly in terms of adhesion, whereas the first showed a stronger impact on the brain endothelium integrity and increased invasive ability. The comparative transcriptome revealed potential brain-metastatic-specific key regulators involved in the aforementioned processes, e.g., the angiogenesis-related factors TNXIP and CXCL1. In addition, the transcriptomes of the two TNBC cell lines strongly differed in certain angiogenesis-associated factors and in several genes related to cell migration and invasion. Based on the present study, we hypothesize that the tumor cell's ability to disrupt the BBB via angiogenesis activation, together with increased cellular motility, is required for BC cells to overcome the BBB and develop brain metastases.

Indexed as

Gene Regulatory NetworksAnimalsBlood-Brain BarrierBrain NeoplasmsBreast NeoplasmsCell CommunicationCell Line, TumorCell MovementFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMCF-7 CellsMiceNeoplasm Transplantationadhesionangiogenesisblood–brain barrierbreast cancer–brain metastasisbreast cancer molecular subtypesgap junction assemblyinvasion

Identifiers

PMID35163822
PMCPMC8836543
OpenAlexW4211075127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.